The Patent Finder
NP

Nexus Pharmaceuticals, LLC

First filing 2020
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Seven patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in May 2040. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
May 2040
Next term end
1
Patent families

When these terms end

Each bar runs from grant to computed term end. 2021 to 2040.
US 11,090,278 Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same May 16, 2040
US 11,464,752 Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same May 16, 2040
US 11,241,400 Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same May 16, 2040
US 11,426,369 Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same May 16, 2040
US 11,478,436 Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same no later than May 16, 2040
US 11,571,398 Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same no later than May 16, 2040
US 12,797,345 Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same May 16, 2040
20252029203320372040
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
Every computed term in this portfolio is shown above.Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.

Fee deadlines

No maintenance fee falls due on this company's record before Nov 17, 2027.

Recent changes

  • 1 of the patents on this record was granted since Aug 22, 2026

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 11,090,278Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
In force
 · High confidence
In forceHigh confidence
US 11,241,400Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
In force
 · High confidence
In forceHigh confidence
US 11,426,369Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
In force
 · Medium confidence
In forceMedium confidence
US 11,464,752Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
In force
 · High confidence
In forceHigh confidence
US 11,478,436Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
In force
 · Medium confidence
In forceMedium confidence
US 11,571,398Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
In force
 · Medium confidence
In forceMedium confidence
US 12,797,345Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
In force
 · Medium confidence
In forceMedium confidence

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
2 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited